RJA
AMGN icon

Raymond James & Associates’s Amgen AMGN Stock Holding History

Raymond James & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,500
Closed -$1.87M – 3795
2023
Q2 		$1.87M Hold
8,500
– – ﹤0.01% 2100
2023
Q1 		$1.87M Buy
+8,500
New +$2.09M ﹤0.01% 2074
2021
Q3 		– Sell
-16,400
Closed -$91K – 4112
2021
Q2 		$91K Sell
16,400
-46,400
-74% -$11.4M ﹤0.01% 3852
2021
Q1 		$159K Buy
62,800
+49,600
+376% +$11.8M ﹤0.01% 3676
2020
Q4 		$15K Sell
13,200
-700
-5% -$161K ﹤0.01% 3710
2020
Q3 		$12K Sell
13,900
-500
-3% -$124K ﹤0.01% 3535
2020
Q2 		$49K Sell
14,400
-1,600
-10% -$365K ﹤0.01% 3379
2020
Q1 		$10K Sell
16,000
-18,000
-53% -$3.93M ﹤0.01% 3437
2019
Q4 		$197K Buy
+34,000
New +$7.49M ﹤0.01% 3351
2019
Q2 		– Sell
-35,100
Closed -$7K – 3630
2019
Q1 		$7K Buy
35,100
+3,900
+13% +$745K ﹤0.01% 3579
2018
Q4 		$19K Sell
31,200
-800
-3% -$156K ﹤0.01% 3436
2018
Q3 		$16K Sell
32,000
-600
-2% -$118K ﹤0.01% 3553
2018
Q2 		$7K Buy
+32,600
New +$5.77M ﹤0.01% 3533
2017
Q3 		– Sell
-10,600
Closed -$90K – 3400
2017
Q2 		$90K Sell
10,600
-25,300
-70% -$4.12M ﹤0.01% 3126
2017
Q1 		$1K Buy
+35,900
New +$5.97M ﹤0.01% 3281
2016
Q4 		– Sell
-38,300
Closed -$163K – 3243
2016
Q3 		$163K Buy
+38,300
New +$6.48M ﹤0.01% 2907

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Raymond James & Associates's AMGN Position: Q3 2024 in Review

Raymond James & Associates reduced its Amgen (AMGN) stake by 7.1% in Q3 2024, selling an estimated $24.7M and leaving 989,504 shares worth $319M. The position accounts for 0.19% of the portfolio, ranked #95.

Raymond James & Associates first reported a position in AMGN in Q2 2013 and has held it in 46 quarters since. The position peaked at $443M in Q3 2020. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Raymond James & Associates held 989,504 shares of Amgen worth $319M as of Q3 2024.
  • Raymond James & Associates sold 75,501 Amgen shares in Q3 2024, an estimated $24.7M.
  • Amgen made up 0.19% of Raymond James & Associates's portfolio in Q3 2024, its #95 holding.
  • Raymond James & Associates first reported a position in Amgen in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's Amgen position peaked at $443M in Q3 2020.
  • 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.